OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
27
Results
Show all
Save search
Copy query
Show results for
Unknown
(27)
Publication Date
Release Date
2021
(9)
2022
(4)
2025
(3)
2024
(3)
2011
(3)
2019
(2)
2026
(1)
2023
(1)
2017
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Not available
S-EPMC8041365
|
biostudies-literature
Cite
Identification of Differential Drought Response Mechanisms in
Medicago sativa
subsp.
sativa
and
falcata
through Comparative Assessments at the Physiological, Biochemical, and Transcriptional Levels.
Not available
S-EPMC8539336
|
biostudies-literature
Cite
Control of physiologic glucose homeostasis via hypothalamic modulation of gluconeogenic substrate availability.
Not available
S-EPMC12332875
|
biostudies-literature
Cite
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Not available
S-EPMC8397301
|
biostudies-literature
Cite
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Not available
S-EPMC8185188
|
biostudies-literature
Cite
Pandemic intake questionnaire to improve quality, effectiveness, and efficiency of outpatient neurologic and developmental care at the Kennedy Krieger institute during the COVID-19 pandemic.
Not available
S-EPMC9583877
|
biostudies-literature
Cite
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial.
Not available
S-EPMC12549478
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Not available
S-EPMC9999055
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets